Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Irma Fredriksson"'
Autor:
Caroline Rönnlund, Emmanouil G. Sifakis, Caroline Schagerholm, Qiao Yang, Emelie Karlsson, Xinsong Chen, Theodoros Foukakis, Jodi Weidler, Michael Bates, Irma Fredriksson, Stephanie Robertson, Johan Hartman
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-13 (2024)
Abstract Background Overexpression of human epidermal growth factor receptor 2 (HER2) caused by HER2 gene amplification is a driver in breast cancer tumorigenesis. We aimed to investigate the prognostic significance of manual scoring and digital imag
Externí odkaz:
https://doaj.org/article/45539500ca624cfc9e0f07721e2b11cd
Autor:
Balazs Acs, Johan Hartman, Demet Sönmez, Henrik Lindman, Anna L.V. Johansson, Irma Fredriksson
Publikováno v:
The Lancet Regional Health. Europe, Vol 40, Iss , Pp 100886- (2024)
Summary: Background: Estrogen receptor-low (ER-low) HER2-negative breast cancer has similar pathological and molecular characteristics as triple-negative breast cancer (TNBC), and it is questionable whether it should be considered a separate entity.
Externí odkaz:
https://doaj.org/article/1a7320845b114517a9e6a5c7e3942941
Autor:
Jacob Thurell, Narges Manouchehri, Irma Fredriksson, Ulla Wilking, Jonas Bergh, Lisa Ryden, Linetta B. Koppert, Maria M. Karsten, Narsis A. Kiani, Elham Hedayati
Publikováno v:
Breast, Vol 70, Iss , Pp 18-24 (2023)
Aim: The main objective of the current study was to explore the value of risk-adjustment when comparing (i.e. benchmarking) long-term overall survival (OS) in breast cancer (BC) between Swedish regions. We performed risk-adjusted benchmarking of 5- a
Externí odkaz:
https://doaj.org/article/7d668ab954db47779308fce2e7ebb230
Autor:
Tommaso De Marchi, Paul Theodor Pyl, Martin Sjöström, Susanne Erika Reinsbach, Sebastian DiLorenzo, Björn Nystedt, Lena Tran, Gyula Pekar, Fredrik Wärnberg, Irma Fredriksson, Per Malmström, Mårten Fernö, Lars Malmström, Johan Malmstöm, Emma Niméus
Publikováno v:
Communications Biology, Vol 6, Iss 1, Pp 1-14 (2023)
A proteogenomic analysis of matching primary breast cancer and ipsilateral breast tumor recurrence (IBTR) samples provides insight into the development of IBTR and may be useful in identifying biomarkers for IBTR formation.
Externí odkaz:
https://doaj.org/article/7fcdfaaf09f349e4a6ae38eff9a3e17b
Autor:
Maria Sund, Miguel Garcia-Argibay, Hans Garmo, Johan Ahlgren, Anna-Karin Wennstig, Irma Fredriksson, Henrik Lindman, Antonis Valachis
Publikováno v:
Breast, Vol 59, Iss , Pp 157-164 (2021)
Background: Prior studies regarding use of Aromatase inhibitors (AIs) and risk for cardiovascular disease (CVD) have shown conflicting results. This retrospective cohort study aimed to investigate whether AIs use affects risk for CVD events in postme
Externí odkaz:
https://doaj.org/article/619d9315569944329cfa7ea7fcaec036
Autor:
Anna-Karin Wennstig, Charlotta Wadsten, Hans Garmo, Mikael Johansson, Irma Fredriksson, Carl Blomqvist, Lars Holmberg, Greger Nilsson, Malin Sund
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Adjuvant radiotherapy (RT) for breast cancer (BC) has been associated with an increased risk of later radiation-induced lung cancer (LC). We examined the risk of primary LC in a population-based cohort of 52300 women treated for BC during 19
Externí odkaz:
https://doaj.org/article/e68af3e3cd214a77a9980ef29abb98aa
Autor:
Anna L. V. Johansson, Cassia B. Trewin, Irma Fredriksson, Kristin V. Reinertsen, Hege Russnes, Giske Ursin
Publikováno v:
Breast Cancer Research, Vol 23, Iss 1, Pp 1-10 (2021)
Abstract Background In breast cancer, immunohistochemistry (IHC) subtypes, together with grade and stage, are well-known independent predictors of breast cancer death. Given the immense changes in breast cancer treatment and survival over time, we us
Externí odkaz:
https://doaj.org/article/c3085dd733f14a578dd68f2ae62888ce
Autor:
Anna-Karin Wennstig, Charlotta Wadsten, Hans Garmo, Irma Fredriksson, Carl Blomqvist, Lars Holmberg, Greger Nilsson, Malin Sund
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-9 (2020)
Abstract Background Adjuvant radiotherapy (RT) for breast cancer (BC) has been associated with an increased risk of ischemic heart disease (IHD). We examined the incidence of IHD in a large population-based cohort of women with BC. Methods The Breast
Externí odkaz:
https://doaj.org/article/b19f89ab856e4a16bfe7841cfa76b84f
Autor:
Gabriella Frisk, Sara Ekberg, Elisabet Lidbrink, Sandra Eloranta, Malin Sund, Irma Fredriksson, Mats Lambe, Karin E. Smedby
Publikováno v:
Breast Cancer Research, Vol 20, Iss 1, Pp 1-10 (2018)
Abstract Background Results from previous studies indicate that use of low-dose aspirin may improve breast cancer prognosis. We evaluated aspirin use and breast cancer outcomes in relation to clinical characteristics as well as dose and duration of a
Externí odkaz:
https://doaj.org/article/5689858d381547e3ae5c9630804fffad
Autor:
Martin Sjöström, Johan Staaf, Patrik Edén, Fredrik Wärnberg, Jonas Bergh, Per Malmström, Mårten Fernö, Emma Niméus, Irma Fredriksson
Publikováno v:
Breast Cancer Research, Vol 20, Iss 1, Pp 1-13 (2018)
Abstract Background Adjuvant radiotherapy is the standard of care after breast-conserving surgery for primary breast cancer, despite a majority of patients being over- or under-treated. In contrast to adjuvant endocrine therapy and chemotherapy, no d
Externí odkaz:
https://doaj.org/article/ff2a63d745da4d41932390437e13265a